Skip to main content
Signal8

FMR LLC

SEC insider (Form 3/4/5 filer). CIK 0000315066. 10% Owner at Structure Therapeutics Inc. (GPCR) and 6 other issuers. 64 reported Form 4/5 transactions since Sep 2024; latest on Jul 22, 2026. Located in BOSTON, MA.

Companies FMR LLC has filed insider reports for

  • Structure Therapeutics Inc. (GPCR): 10% Owner
  • Beam Therapeutics Inc. (BEAM): 10% Owner
  • Avalyn Pharma Inc. (AVLN): 10% Owner
  • Rallybio Corp (RLYB): 10% Owner
  • Metsera, Inc. (MTSR): 10% Owner
  • Sana Biotechnology, Inc. (SANA): 10% Owner
  • Bicara Therapeutics Inc. (BCAX)
FMR LLC profile photo

FMR LLC

CIK: 0000315066

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)34 (53.1%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)30 (46.9%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (7)

Structure Therapeutics Inc. logo
GPCR

Structure Therapeutics Inc.

10% Owner
Beam Therapeutics Inc. logo
BEAM

Beam Therapeutics Inc.

10% Owner
Avalyn Pharma Inc. logo
AVLN

Avalyn Pharma Inc.

10% Owner
Rallybio Corp logo
RLYB

Rallybio Corp

10% Owner
Metsera, Inc. logo
MTSR

Metsera, Inc.

10% Owner
Sana Biotechnology, Inc. logo
SANA

Sana Biotechnology, Inc.

10% Owner
Bicara Therapeutics Inc. logo
BCAX

Bicara Therapeutics Inc.

Discretionary Trading P&L

Holdings

Transaction History (64 total)

  • Structure Therapeutics Inc. logo
    GPCR

    Structure Therapeutics Inc.

    Jul 22, 2026
    Sale

    American Depositary Shares

    Indirect
    1.4K shares at avg. $50.07-
  • Structure Therapeutics Inc. logo
    GPCR

    Structure Therapeutics Inc.

    Jul 22, 2026
    Sale

    American Depositary Shares

    Indirect
    16.1K shares at avg. $50.07-
  • Beam Therapeutics Inc. logo
    BEAM

    Beam Therapeutics Inc.

    Jun 26, 2026
    Sale
    Indirect
    251.5K shares at avg. $35.26$8.9M
  • Beam Therapeutics Inc. logo
    BEAM

    Beam Therapeutics Inc.

    Jun 25, 2026
    Sale
    Indirect
    33.4K shares at avg. $35.12$1.2M
  • Avalyn Pharma Inc. logo
    AVLN

    Avalyn Pharma Inc.

    May 1, 2026
    Conversion
    Indirect
    377.9K shares-
  • Avalyn Pharma Inc. logo
    AVLN

    Avalyn Pharma Inc.

    May 1, 2026
    Conversion
    Indirect
    80.3K shares-
  • Avalyn Pharma Inc. logo
    AVLN

    Avalyn Pharma Inc.

    May 1, 2026
    Conversion
    Indirect
    225.8K shares-
  • Avalyn Pharma Inc. logo
    AVLN

    Avalyn Pharma Inc.

    May 1, 2026
    Conversion
    Indirect
    727.6K shares-
  • Avalyn Pharma Inc. logo
    AVLN

    Avalyn Pharma Inc.

    May 1, 2026
    Conversion
    Indirect
    872.9K shares-
  • Structure Therapeutics Inc. logo
    GPCR

    Structure Therapeutics Inc.

    Apr 14, 2026
    Sale

    American Depositary Shares

    Indirect
    16.1K shares at avg. $55.07-

1-10 of 64

…